http://www.fiercebiotech.com/story/phiii-flop-top-boston-cancer-stem-cell-program-batters-dainippon-sumitomo/2014-05-27
We/Sunovion never had a shot at these drugs, the message was clearly sent last year in spite or RR's best attempts to sell us a future. If anything today's new expedites our piecemeal sell off sooner vs already scheduled.
From HQ perspective we all know, or should know, game's over. The time to leave is now or hang in for package depending upon personal situation. Good luck all.
Yet another winning move by Tada and our Japanese parents. First was the purchase an obliteration of Separacor. Throwing good money after bad on Laturda (has this drug turned a profit yet?) and Craptiom (broken 100 scripts yet?). Now this?!? DSP bet the farm on BBI. Make sure you visit the booth at ASCO!
Just listened to the investor call on the DSP website. You should listen too. It is so clear that the Japanese have NO CLUE what they are doing, and have no business being in the oncology business. What a total waste of $2B!
Just listened to the investor call on the DSP website. You should listen too. It is so clear that the Japanese have NO CLUE what they are doing, and have no business being in the oncology business. What a total waste of $2B! Yesterday 10:23 PM You just now figuring out that they don't know what they're doing? Most of us figured that out within 30 days of them buying Sepracor (Sepahko(